Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
77,450,966
-
Share change
-
+5,246,496
-
Total reported value
-
$8,561,346,651
-
Put/Call ratio
-
83%
-
Price per share
-
$110.54
-
Number of holders
-
357
-
Value change
-
+$599,287,042
-
Number of buys
-
194
-
Number of sells
-
140
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q3 2022
As of 30 Sep 2022,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
357 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,450,966 shares.
The largest 10 holders included
VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., Avoro Capital Advisors LLC, EcoR1 Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and Bank of New York Mellon Corp.
This page lists
360
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.